|
1
|
Rodríguez A, Dueñas-Gonzalez A and
Delgado-Pelayo S: Clinical presentation and management of uveal
melanoma. Mol Clin Oncol. 5:675–677. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Char DH, Stone RD, Irvine AR, Crawford JB,
Hilton GF, Lonn LI and Schwartz A: Diagnostic modalities in
choroidal melanoma. Am J Ophthalmol. 89:223–230. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Kanski J and Bowling B: Clinical
Ophthalmology: A Systematic Approach (7th ed). Elsevier/Saunders;
New York: pp. 501–504. 2011
|
|
4
|
Kujala E, Makitie T and Kivela T: Very
long-term prognosis of patients with malignant uveal melanoma.
Invest Ophthalmol Visual Sci. 44:4651–4659. 2003. View Article : Google Scholar
|
|
5
|
Shields CL, Kaliki S, Furuta M, Mashayekhi
A and Shields JA: Clinical spectrum and prognosis of uveal melanoma
based on age at presentation in 8,033 cases. Retina. 32:1363–1372.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sisley K, Rennie IG, Parsons MA, Jacques
R, Hammond DW, Bell SM, Potter AM and Rees RC: Abnormalities of
chromosomes 3 and 8 in posterior uveal melanoma correlate with
prognosis. Genes Chromosomes Cancer. 19:22–28. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Van Raamsdonk CD, Griewank KG, Crosby MB,
Garrido MC, Vemula S, Wiesner T, Obenauf AC, Wackernagel W, Green
G, Bouvier N, et al: Mutations in GNA11 in uveal melanoma. N
Engl J Med. 363:2191–2199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Van Raamsdonk CD, Bezrookove V, Green G,
Bauer J, Gaugler L, O'Brien JM, Simpson EM, Barsh GS and Bastian
BC: Frequent somatic mutations of GNAQ in uveal melanoma and blue
naevi. Nature. 457:599–602. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Buecher B, Gauthier-Villars M, Desjardins
L, Lumbroso-Le Rouic L, Levy C, De Pauw A, Bombled J, Tirapo C,
Houdayer C, Bressac-de Paillerets B, et al: Contribution of
CDKN2A/P16 (INK4A), P14 (ARF), CDK4 and
BRCA1/2 germline mutations in individuals with suspected
genetic predisposition to uveal melanoma. Fam Cancer. 9:663–667.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Abdel-Rahman MH, Pilarski R, Cebulla CM,
Massengill JB, Christopher BN, Boru G, Hovland P and Davidorf FH:
Germline BAP1 mutation predisposes to uveal melanoma, lung
adenocarcinoma, meningioma, and other cancers. J Med Genet.
48:856–859. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ferguson R, Vogelsang M, Ucisik-Akkaya E,
Rai K, Pilarski R, Martinez CN, Rendleman J, Kazlow E, Nagdimov K,
Osman I, et al: Genetic markers of pigmentation are novel risk loci
for uveal melanoma. Sci Rep. 6:311912016.doi:10.1038/srep31191.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Harbour JW, Roberson ED, Anbunathan H,
Onken MD, Worley LA and Bowcock AM: Recurrent mutations at codon
625 of the splicing factor SF3B1 in uveal melanoma. Nat
Genet. 45:133–135. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
13
|
Martin M, Maßhöfer L, Temming P, Rahmann
S, Metz C, Bornfeld N, van de Nes J, Klein-Hitpass L, Hinnebusch
AG, Horsthemke B, et al: Exome sequencing identifies recurrent
somatic mutations in EIF1AX and SF3B1 in uveal
melanoma with disomy 3. Nat Genet. 45:933–936. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Onken MD, Worley LA, Char DH, Augsburger
JJ, Correa ZM, Nudleman E, Aaberg TM Jr, Altaweel MM, Bardenstein
DS, Finger PT, et al: Collaborative Ocular Oncology Group report
number 1: Prospective validation of a multi-gene prognostic assay
in uveal melanoma. Ophthalmology. 119:1596–1603. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Speicher MR, Prescher G, du Manoir S,
Jauch A, Horsthemke B, Bornfeld N, Becher R and Cremer T:
Chromosomal gains and losses in uveal melanomas detected by
comparative genomic hybridization. Cancer Res. 54:3817–3823.
1994.PubMed/NCBI
|
|
16
|
Weis E, Shah CP, Lajous M, Shields JA and
Shields CL: The association between host susceptibility factors and
uveal melanoma: A meta-analysis. Arch Ophthalmol. 124:54–60. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Seddon JM, Gragoudas ES, Glynn RJ, Egan
KM, Albert DM and Blitzer PH: Host Factors, UV radiation, andrisk
of uveal melanoma. Arch Ophthalmol. 108:1274–1280. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Smith JH, Padnick-Silver L, Newlin A,
Rhodes K and Rubinstein WS: Genetic study of familial uveal
melanoma: Association of uveal and cutaneous melanoma with
cutaneous and ocular nevi. Ophthalmology. 114:774–779. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kath R, Hayungs J, Bornfeld N, Sauerwein
W, Hoffken K and Seeber S: Prognosis and treatment of disseminated
uveal melanoma. Cancer. 72:2219–2223. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shields C, Materin M, Shields J,
Gershenbaum E, Singh A and Smith A: Factors associated with
elevated intraocular pressure in eyes with iris melanoma. Br J
Ophthalmol. 85:666–669. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kanski J: Signs in Ophthalmology: Causes
and differential diagnosis. 66824th edition. Elsevier; New York,
NY: pp. 310–318. 2010
|
|
22
|
Singh P and Singh A: Choroidal melanoma.
Oman J Ophthalmol. 5:3–9. 2012. View Article : Google Scholar : PubMed/NCBI
|
